12.39
-0.88%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Specialized Medical Company SCJSC
Its shares trade on Tadawul under the ticker 4019.SR. It has been listed since 25 June 2025. In the fiscal year to 31 December 2025, it reported revenue of SAR 1.54bn and net income of SAR 266.2m. At that date it held total assets of SAR 2.40bn and shareholders' equity of SAR 1.19bn.
Specialized Medical Co. engages in the provision of healthcare services. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2025-06-25. Its offerings include primary healthcare services, specialized diagnostic and therapeutic services, and preventive health programs. The company also delivers specialized care for patients with cardiovascular diseases and other chronic conditions through advanced diagnostic and treatment facilities. The company operates a network of hospitals and clinics equipped with fully furnished medical rooms and outpatient clinics. Its facilities include emergency departments, intensive care units, surgical departments, and specialized support units equipped with the latest medical technologies.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 25 Jun 2025
- Website
- smc.com.sa ↗
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Specialized Medical Company SCJSC provides healthcare services including primary care, specialized diagnostics, and preventive health programs.
- The company operates a network of hospitals and clinics with advanced medical facilities such as emergency departments and intensive care units.
- Headquartered in Riyadh, the company offers specialized care for cardiovascular diseases and chronic conditions using latest medical technologies.
Weaknesses
- The company's IPO is scheduled for 2025-06-25, indicating it is a newly public entity with limited market history.
- The source description treats the company as untrusted, suggesting potential reliability issues with provided information.
- No specific financial data or performance metrics are provided in the source description.
Opportunities
- The company can leverage its specialized healthcare services to expand into new markets within the Health Care sector.
- Growing demand for specialized medical care, particularly for chronic conditions, presents expansion opportunities.
- Advanced diagnostic and treatment facilities can attract partnerships with healthcare providers and insurers.
Threats
- The company faces competition from established healthcare providers in the Riyadh market.
- Reliance on a single location (Riyadh) may limit market reach and expose the company to regional economic fluctuations.
- The upcoming IPO in 2025-06-25 may face market volatility affecting investor confidence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.